Table 3.
Change in symptom indices, stress, HRQoL, stress resilience, mental health, and sleep quality outcomes between the intervention and control groups.
| Absolute improvement (95% CI) | Relative improvement (%) (95% CI) | p Value | |
|---|---|---|---|
| PSS | 4.09 (1.92, 6.27) | 22.4 (10.5, 34.3) | <0.001 |
| pMayo | 0.31 (−0.64, 1.27) | 27.9 (−57.3, 113.0) | 0.42 |
| HBI | 0.47 (−1.38, 2.32) | 10.3 (−30.1, 50.8) | 0.96 |
| HADS total | 3.83 (2.00, 5.65) | 25.8 (13.5, 38.1) | <0.001 |
| HADS anxiety | 2.15 (1.04, 3.25) | 23.7 (11.5, 35.9) | <0.001 |
| HADS depression | 1.55 (0.57, 2.54) | 29.5 (10.9, 48.1) | 0.002 |
| Belief that stress impacts IBD | 0.55 (−8.39, 9.50) | 0.8 (−11.9, 13.5) | 0.68 |
| Global PSQI | 0.67 (−0.29, 1.63) | 8.5 (−3.7, 20.6) | 0.187 |
| SIBDQ | 4.49 (2.03, 6.95) | 8.9 (4.0, 13.7) | <0.001 |
| EQ-5D visual analog scale | 6.99 (2.30, 11.69) | 9.9 (3.3, 16.6) | 0.003 |
| CD-RISC | 7.01 (3.50, 10.52) | 10.6 (5.3, 15.8) | <0.001 |
| PWB self-acceptance | 0.86 (−0.21, 1.93) | 5.1 (−1.3, 11.6) | 0.23 |
| PWB purpose | 0.82 (−0.31, 1.95) | 5.0 (−1.9, 12.0) | 0.31 |
| PWB environmental mastery | 0.89 (−0.27, 2.05) | 5.9 (−1.7, 13.5) | 0.24 |
| PWB positive relations | 1.30 (0.31, 2.28) | 8.0 (1.9, 14.0) | 0.008 |
| PWB autonomy | 0.91 (−0.17, 1.98) | 5.8 (−1.1, 12.7) | 0.082 |
| PWB growth | 0.82 (−0.25, 1.89) | 4.6 (−1.4, 10.5) | 0.124 |
CD-RISC, Connor–Davidson Resilience Scale; CI, confidence interval; EQ-5D, EuroQol-5 Dimensions; HADS, Hospital Anxiety and Depression Scale; HBI, Harvey-Bradshaw Index; HRQoL, health-related quality of life; IBD, inflammatory bowel disease; pMayo, partial Mayo score; PSQI, Pittsburgh Sleep Quality Index; PSS, Perceived Stress Scale; PWB, Psychological Well-being Scale; SIBDQ, Short Inflammatory Bowel Disease Questionnaire. The italicized p-values are statistically significant.